Articles tagged "Graft failure"

2016 American Transplant Congress
Assessment of Molecular Mechanisms of Non-Transplant Cardiac Hypertrophy in Cardiac Allograft Hypertrophy – An Exploratory Gene Array Study of Myocardial Biopsy Samples.
R. Araujo-Gutiérrez,^1,2 S. Ibarra-Cortez,^1,2 M. Park,¹ J. Estep,¹ G. Ashrith,¹ B. Trachtenberg,¹ G. Torre-Amione,¹ K. Youker,^1,2 A. Bhimaraj.¹
¹Houston Methodist DeBakey Heart & Vascular Center, Houston, TX; ²Houston Methodist Research Institute, Houston, TX.
Cardiac Allograft Hypertrophy (CAH) develops in up to 80% of patients as early as six months post-transplant, and is associated with decreased quality of life…
2016 American Transplant Congress
Urinary CXCL9 Protein as Biomarker for BK Polyoma Viremia.
N. Sarabu,¹ R. El-Rifai,² J. Augustine,¹ A. Padiyar,¹ A. Huml,¹ T. Young,¹ V. Rodriguez,¹ D. Hricik.¹
¹Division of Nephrology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; ²Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
Introduction: BK infection is common in kidney transplant patients and can result in accelerated loss of allografts. Management involves empiric lowering of immunosuppression, which can…
2016 American Transplant Congress
Duodenal Graft Complications After Pancreas Transplant: Evolving Management.
D. Al-Adra,¹ J. Laurence,² A. Norgate,¹ N. Goldaracena,¹ M. Marquez,¹ A. Barbas,¹ M. Dib,¹ M. Selzner,¹ M. Cattral.¹
¹Department of Surgery, Toronto General Hospital, University of Toronto, Toronto, ON, Canada; ²Royal Prince Alfred Institute of Academic Surgery, University of Sydney, Sydney, New South Wales, Australia.
Introduction Pancreas transplantation is an established treatment for insulin-dependent-diabetes-mellitus with renal failure. However, complications relating to the transplant duodenum remain a significant cause of morbidity…
2016 American Transplant Congress
Prolonged Pre-Transplant Dialysis Duration Reverses the “Nephroprotective Effect” in Simultaneous Liver-Kidney Transplant Recipients.
M. Casey, X. Wen, A. Santos, S. Rehman, K. Womer.
University of Florida, Gainesville.
Past literature has suggested that simultaneous liver-kidney(SLK) transplant recipients may experience a nephroprotective effect compared to kidney(Ki) alone transplant recipients. Since hepatorenal syndrome is a…
2016 American Transplant Congress
Post-Transplantation Hypomagnesemia as a Predictor of Survival Among the Kidney Transplant Population.
T. Hod, B. Patibandla, A. Chandraker.
Transplant Research Center, Brigham and women's hospital, Boston, MA.
We have previously shown a robust relationship between low magnesium in the first year post-transplant and better long-term kidney allograft function. Given this somewhat counterintuitive…
2016 American Transplant Congress
Subnormothermic Machine Perfusion (SNMP) with a Novel Hemoglobin-Based Oxygen Carrier (HBOC) Solution for Ex Vivo Preservation in Vascularized Composite Allotransplantation (VCA).
S. Oksuz, R. Schweizer, M. Minervini, B. Banan, V. Gorantla, P. Fontes.
University of Pittsburgh, Pittsburgh.
Background: Improved preservation techniques could reduce ischemia-reperfusion injuries (IRI) and allow better matching and allocation of VCA grafts across wider distances. A novel SNMP system…
2016 American Transplant Congress
Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
T. Zens, G. Leverson, R. Redfield, P. Chlebeck, L. Zitur, D. Kaufman, L. Fernandez.
Surgery, University of Wisconsin, Madison, WI.
Introduction: Renal transplant outcomes are a result of a combination of donor and recipient factors. In 2014, the nomenclature used to describe donor quality was…
2016 American Transplant Congress
Diabetes Mellitus and Kidney Transplant Outcomes.
A. Mehrnia,¹ A. Wang,¹ W. Chaiwatcharayut,² E. Huang,¹ S. Bunnapradist.¹
¹Nephrology, University of California-Los Angeles, Los Angeles, CA; ²Internal Medicine, Albert Einstein University, Bronx, NY.
Background:This study investigates the impact of pre-existing (PDM) and new onset diabetes (NODAT) on the graft and patient survival after kidney transplant.Methods:The UNOS database was…
2016 American Transplant Congress
Minimum Graft Size Avoiding Small-for-Size Associated Early Graft Failure in Living Donor Liver Transplantation.
S. Marubashi,¹ H. Nagano,³ H. Eguchi,² H. Wada,² K. Umeshita,² Y. Doki,² M. Mori,² N. Sato,¹ T. Kimura,¹ A. Kenjyo,¹ M. Gotoh.¹
¹Regenerative Surgery, Fukushima Medical University, Fukushima, Japan; ²Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
Small-for-size syndrome (SFSS) is a serious complication in living donor liver transplantation (LDLT). The aim of this study was to investigate the risk factors for…
2016 American Transplant Congress
Original KDRI Predicts Kidney Graft Failure in a Brazilian Cohort.
J. Reusing Jr.,¹ C. Nihei,¹ A. Lino de Souza,² E. David-Neto,¹ C. Ventura.³
¹Kidney Transplant Unit, Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, SP, Brazil; ²Psychobiology Department, Universidade Federal de São Paulo, São Paulo, SP, Brazil; ³Renal Transplant Unit, Hospital das Clinicas of the University of Sao Paulo Medical School, São Paulo, SP, Brazil.
Current US allocation system for kidney transplantation (KT) is based on KDRI (Kidney Donor Risk Index). In Brazil, it is still based on HLA-compatibility; donor…